Drawing for CRISTINAGENIX

USPTO serial 97106611

CRISTINAGENIX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
DUBIN, DAVID I
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CRISTINAGENIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel J. Noblitt

Daniel J. Noblitt NOBLITT & NEWSON, PLLC8777 North Gainey Center Drive, Ste. 175Scottsdale, AZ 85258UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Moleskin for medical purposes; Moleskin for use as a medical bandageABANDONEDJan 24, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2022MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Oct 31, 2022ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 25, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 6, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2022AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Aug 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2022IUAAUSE AMENDMENT ACCEPTED—
Aug 12, 2022DOCKASSIGNED TO EXAMINER—
May 5, 2022AUPCAMENDMENT TO USE PROCESSING COMPLETE—
May 5, 2022IUAFUSE AMENDMENT FILED—
May 4, 2022EAAUTEAS AMENDMENT OF USE RECEIVED—
Jan 31, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 31, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance